Gilead downgraded to Market Perform from Outperform at Leerink
Downside risk from downgrade.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Downside risk from downgrade.
What happened, with direct paths to the underlying reporting
Target 127; price 133.21; downgrade.
Target: $127
Posted price: $133.21
Analyst firm: Leerink Partners
Analyst: Daina Graybosch
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.